Why AMR is a global crisis? – critically evaluation of the health and economic aspect of anti microbial resistance

According to the updated WHO Global Action Plan on Antimicrobial Resistance (GAP-AMR 2026–2036), adopted at the 79th World Health Assembly in May 2026, AMR is no longer just a healthcare problem—it is a global development, economic, food security, and national security crisis.  

1. AMR is already causing millions of deaths every year

  • Drug-resistant bacterial infections were directly responsible for 1.27 million deaths globally in 2019.
  • AMR contributed to 4.95 million deaths worldwide in the same year.
  • This makes AMR comparable to, or greater than, many major infectious diseases in terms of mortality burden.  

2. The burden is projected to grow dramatically by 2050

  • Recent global modelling suggests AMR could cause 1.91 million direct deaths annually by 2050.
  • AMR-associated deaths could reach 8.22 million per year if current trends continue.
  • Several international assessments warn that cumulative deaths from AMR could exceed 39 million between 2025 and 2050.  

3. AMR threatens modern medicine itself

  • Routine medical procedures such as cancer chemotherapy, organ transplantation, neonatal care, intensive care treatment, and major surgeries depend on effective antibiotics.
  • When antimicrobials stop working, common infections become difficult or impossible to treat, increasing mortality, complications, and healthcare costs.
  • WHO identifies AMR as one of the most serious threats to health systems globally.  

4. AMR creates a massive economic burden

  • The United Nations Environment Programme estimates that unchecked AMR could reduce global GDP by US$3.4 trillion annually.
  • It could push 24 million additional people into extreme poverty over the next decade.
  • Other global estimates project cumulative economic losses approaching US$100 trillion by 2050.  

5. AMR is a One Health crisis affecting humans, animals, food systems and the environment

  • WHO’s updated 2026–2036 Action Plan emphasizes that AMR spreads across human health, livestock, agriculture, food production, water systems and the environment.
  • Data from WHO’s GLASS surveillance network indicate that approximately 1 in 6 bacterial infections reported globally in 2023 showed resistance to antibiotic treatment.
  • This threatens food security, animal health, trade, and environmental sustainability in addition to human health.  

Executive Summary for Presentations

Why AMR is a Global Crisis Key Data
Human deaths 1.27 million direct deaths; 4.95 million associated deaths annually
Future mortality Up to 8.22 million AMR-associated deaths per year by 2050
Healthcare impact Threatens surgery, ICU care, cancer treatment, transplants
Economic impact Up to US$3.4 trillion GDP loss annually; US$100 trillion cumulative losses by 2050
One Health impact Affects humans, animals, agriculture, food systems, and environment

These figures are a major reason the WHO Member States adopted the new GAP-AMR 2026–2036 with targets to reduce AMR-associated deaths, strengthen surveillance, improve infection prevention, expand vaccination, and promote responsible antimicrobial use across all sectors.

Source: WHO, UN & other global reports.   

 

Tags: